These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1191 related items for PubMed ID: 28640470
1. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting. Miltoft CB, Rode L, Ekelund CK, Sundberg K, Kjaergaard S, Zingenberg H, Tabor A. Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470 [Abstract] [Full Text] [Related]
2. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test. Galeva S, Konstantinidou L, Gil MM, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581 [Abstract] [Full Text] [Related]
3. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing. Lindquist A, Poulton A, Halliday J, Hui L. Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487 [Abstract] [Full Text] [Related]
4. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study. Lindquist A, Hui L, Poulton A, Kluckow E, Hutchinson B, Pertile MD, Bonacquisto L, Gugasyan L, Kulkarni A, Harraway J, Howden A, McCoy R, Da Silva Costa F, Menezes M, Palma-Dias R, Nisbet D, Martin N, Bethune M, Poulakis Z, Halliday J. Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225 [Abstract] [Full Text] [Related]
6. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ekelund CK, Petersen OB, Skibsted L, Kjaergaard S, Vogel I, Tabor A, Danish Fetal Medicine Research Group. Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566 [Abstract] [Full Text] [Related]
9. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study. Sánchez-Durán MÁ, Bernabeu García A, Calero I, Ramis Fossas J, Illescas T, Avilés MT, Maiz N, Carreras E. BMC Pregnancy Childbirth; 2019 Aug 01; 19(1):274. PubMed ID: 31370808 [Abstract] [Full Text] [Related]
10. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China. Liu Y, Liu H, He Y, Xu W, Ma Q, He Y, Lei W, Chen G, He Z, Huang J, Liu J, Liu Y, Huang Q, Yu F. Hum Genomics; 2020 Jun 05; 14(1):21. PubMed ID: 32503639 [Abstract] [Full Text] [Related]
13. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies. Zakaria H, Kleinfinger P, Lohmann L, Costa JM, Tsatsaris V, Salomon LJ, Jouannic JM, Rosenblatt J, Demain A, Benachi A, El Khattabi L, Vivanti AJ. Prenat Diagn; 2024 May 05; 44(5):555-561. PubMed ID: 38448008 [Abstract] [Full Text] [Related]
19. Atypicality index as an add-on to combined first-trimester screening for chromosomal aberrations. Gadsbøll K, Vogel I, Pedersen LH, Kristensen SE, Wright A, Wright D, Petersen OB. Ultrasound Obstet Gynecol; 2024 Jun 05; 63(6):798-806. PubMed ID: 38112514 [Abstract] [Full Text] [Related]
20. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES]. Chaveeva P, Yankova M, Stratieva V, Dimitrov I, Shterev A. Akush Ginekol (Sofiia); 2016 Jun 05; 55(2):10-5. PubMed ID: 27509651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]